Brandt C M, Wees-Ponchon A, Nisand G, Verdun A, Jobard P, Attali P, Bousquet P, Fincker J L
Unité de recherche clinique, Hôpital Civil, Strasbourg.
Arch Mal Coeur Vaiss. 1994 Jul;87(7):861-8.
A retrospective analysis without exclusion of 369 consecutive cases of myocardial infarction admitted between January 1988 and March 1992 studied the risk factors, previous medical history and treatment in this period during which medical practice seemed to be standardised with acknowledged benefits of thrombolysis, beta-blockade and aspirin therapy. The population observed is divided in three age groups (< 65, > 65 < 75 and > 75). A Cox model multivariate analysis for age, sex, diabetes, hypertension, hypercholesterolaemia, tobacco smoking, previous infarction, coronary artery disease and cardiac failure underlined the risk related to age which was 3.2 for patients 65-75 years of age and 4 for patients over 75 years of age. The risk was high in women (1.4), diabetes (1.5) and previous infarction (1.7). The excess mortality of the elderly age groups could also have been related to medical management as the most effective treatments were less commonly used. Thrombolysis was used in 44% of patients under 65 years of age but in only 9.7% of patients over 75 years; betablockers were prescribed in 77.6% of the younger but only in 27.4% of the older patients. The same tendency was observed in the administration of aspirin, with 81.6% receiving this drug in the younger patients compared to only 61% in older patients. Differences in survival at 6 months according to age (93.6%, 74% and 54.9%) show that there is a clearly defined therapeutic objective over 65 years of age with a large field of action and a probability of significant improvement in mortality and morbidity.
对1988年1月至1992年3月间收治的369例连续心肌梗死病例进行了无排除标准的回顾性分析,研究了这一时期的危险因素、既往病史和治疗情况,在此期间医疗实践似乎已标准化,溶栓、β受体阻滞剂和阿司匹林治疗已被公认具有益处。观察人群分为三个年龄组(<65岁、>65<75岁和>75岁)。对年龄、性别、糖尿病、高血压、高胆固醇血症、吸烟、既往梗死、冠状动脉疾病和心力衰竭进行的Cox模型多变量分析强调了与年龄相关的风险,65 - 75岁患者的风险为3.2,75岁以上患者的风险为4。女性(1.4)、糖尿病(1.5)和既往梗死(1.7)患者的风险较高。老年年龄组的额外死亡率也可能与医疗管理有关,因为最有效的治疗方法较少使用。65岁以下患者中有44%接受了溶栓治疗,但75岁以上患者中只有9.7%;β受体阻滞剂在年轻患者中的处方率为77.6%,而在老年患者中仅为27.4%。阿司匹林的使用也观察到了同样的趋势,年轻患者中81.6%接受了这种药物,而老年患者中只有61%。根据年龄划分的6个月生存率差异(93.6%、74%和54.9%)表明,65岁以上有明确的治疗目标,有很大的行动空间,死亡率和发病率有显著改善的可能性。